(66444-1-Ig)

反应种属:Human, Mouse, Rat
抗原名称:AKT1
应用:WB, IHC, ELISA, FCM, IF/ICC
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
Positive WB detected inCalyculin A treated PC-3 cells, Calyculin A treated HEK-293T cells, HSC-T6 cells, TPA treated Jurkat cells, Calyculin A treated HSC-T6 cells
Positive IHC detected inhuman breast cancer tissue, Calyculin A treated Jurkat cells, human colon cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inCalyculin A treated HeLa cells
Positive FC (Intra) detected inCalyculin A treated PC-3 cells

推荐稀释比例

  • Western Blot (WB)1:2000-1:10000
  • Immunohistochemistry (IHC)1:100-1:400
  • Immunofluorescence (IF)/ICC1:200-1:800
  • Flow Cytometry (FC) (INTRA)0.50 ug per 10^6 cells in a 100 µl suspension

推荐稀释说明

It is recommended that this reagent should be titrated in each testing system to obtain optimal results. Sample-dependent, Check data in validation data gallery.

详细信息

宿主/亚型Mouse / IgG1
抗体类型Monoclonal
产品类型Antibody
全称v-akt murine thymoma viral oncogene homolog 1
实际/观测分子量60-62 kDa
产品形式Liquid
偶联物Unconjugated
缓冲液配方PBS, Azide, Glycerol PBS Only
储存缓冲液PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage.
纯化方式Protein A purification
GenBank蛋白编号NM_005163
基因名称AKT1
Gene ID207
RRIDAB_2782958
UniProt IDP31749

背景信息

1) What is AKT? The serine/threonine kinase B AKT pathway (also known as the PI3K-Akt pathway) plays a vital role in the regulation of cellular processes, including cell proliferation, survival, and growth - processes that are essential for oncogenesis. Mutation of the regulator proteins PI3K and PTEN causes uncontrolled disruption within the PI3-kinase pathway, leading to the development of human cancers (1,2; see also AKT pathway poster for more details). 2) phospho-AKT and FAQs A) What is the best way to normalize phosphorylated proteins analyzed by western blot? Normalize phospho-AKT and total AKT with your loading control (e.g. Actin, tubulin), then calculate the phospho/total ratio using these normalized values. Put more simply 1. Calculate the ratio of band intensities of a phospho-AKT band: the loading control. 2. Calculate the ratio of band intensities of total AKT: loading control. 3. Divide ratio obtained #1 by #2 to obtain a normalized value for comparison among different conditions. This procedure allows one to distinguish between a change in AKT expression and a change in the ratio of phospho-AKT. * If you are looking at the differences in a phospho-AKT expression resulting from an experimental condition (e.g., knockdown), you should also show the expression of total AKT to distinguish between a change in AKT expression (transcription/translation level) and a change in the AKT phosphorylation status. B) What is the observed molecular weight for AKT and phospho-AKT? Molecular Weight AKT - 56 kDa Molecular Weight phospho-AKT - 60 kDa (Figure 1) Figure 1. WB: HEK-293 cell lysate was subjected to SDS PAGE followed by western blot with 60203-2-Ig (AKT antibody) and 66444-1-Ig (AKT-phospho-S473 antibody) at a dilution of 1:4000 incubated at room temperature for 1.5 hours. C) Are there any special WB conditions to optimize staining of a phospho-AKT? Since this is a phosphorylated protein, 5% BSA is recommended over non-fat milk as a blocking agent. D) What are good positive and negative controls for a phospho-AKT? - Positive Control: HEK293 cells - Negative Control: Treatment with PI3K inhibitors (e.g. wortmannin) E) What species does this antibody react with? Our internal testing has confirmed that it reacts with the human and mouse forms of phospho-AKT.Reactivity with the human form is also supported by the literature's citations of this antibody . References 1. Perturbations of the AKT signaling pathway in human cancer. 2. Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

文献引用 (375)

Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells

具有新型胞内模块的嵌合抗原受体可提高T细胞的抗肿瘤活性

Pengju Wang # ,Yiyi Wang # ,Xiaojuan Zhao # ,Rui Zheng ,Yiting Zhang ,Ruotong Meng ,Hao Dong ,Sixin Liang ,Xinyi He ,Yang Song ,Haichuan Su ,Bo Yan ,An-Gang Yang ,Lintao Jia

Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma.

靶向 AKT 是治疗 SOX2 阳性、化疗耐药性骨肉瘤的一种有前景的策略

Liu Yujie, Kang Li, Luo Jing, Yang Minglei, Wang Da, Ye Juelan, Yang Xinghai, Wan Wei, Wong Jiemin, Xiao Jianru

Accumulation of Damaging Lipids in the Arf1-Ablated Neurons Promotes Neurodegeneration through Releasing mtDNA and Activating Inflammatory Pathways in Microglia.

Arf1 缺失神经元中有害脂质的积累通过释放 mtDNA 和激活小胶质细胞中的炎症通路促进神经退行性变

Li Xu, Jin Shuhan, Wang Danke, Wu Ying, Tang Xiaoyu, Liu Yufan, Yao Tiange, Han Shoufa, Sun Lin, Wang Yuetong, Hou Steven X

C1q(+) Macrophage-Tumor Cell Interaction Promoted Tumorigenesis via GPR17/PI3K/AKT Pathway Induced DNA Hypermethylation in Nasopharyngeal Carcinoma.

C1q(+)巨噬细胞-肿瘤细胞相互作用通过GPR17/PI3K/AKT通路诱导鼻咽癌DNA高甲基化促进肿瘤发生

Liu Yunzhi, Huang Cuicui, Luo Min, Lu Wenfu, Zhang Baifeng, Bai Lu, Zheng Shuyue, Tan Yanan, Li Shanshan, Wang Huali, Gong Lanqi, Guan Xinyuan

Nanodelivery of Y-27632 by RGD-modified liposome enhances radioimmunotherapy of hepatocellular carcinoma via tumor microenvironment matrix stiffness reprogramming.

通过RGD修饰的脂质体纳米递送Y-27632,通过肿瘤微环境基质硬度重编程增强肝细胞癌的放射免疫疗法

Shen Yang, Zheng Zihui, Hu Xinyao, Zhou Zhuolin, Xu Yangtao, Wang Siyu, Yu Shuhong, He Xiaoqin, Xu Ximing

Targeting PSMD14 combined with arachidonic acid induces synthetic lethality via FADS1 m6A modification in triple-negative breast cancer

靶向PSMD14联合花生四烯酸可通过FADS1 m6A修饰诱导三阴性乳腺癌的合成致死效应

Yuanhang Yu,Jin Hu,Wenwen Wang,Hao Lei,Zihan Xi,Peiyi Zhang,Ende Zhao,Chong Lu,Hengyu Chen,Chunping Liu,Lei Li

Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis.

曲克芦丁通过 CD155/SRC/β-catenin 信号轴抑制骨肉瘤的干性

Chen Junkai, Li Hongbo, Jin Qinglin, Li Xiaoguang, Zhang Yiwen, Shen Jingnan, Huang Gang, Yin Junqiang, Zou Changye, Li Xinyu, He Xin, Xie Xianbiao, Lin Tiao

Sustained release of miR-21 carried by mesenchymal stem cell-derived exosomes from GelMA microspheres inhibits ovarian granulosa cell apoptosis in premature ovarian insufficiency.

GelMA微球中间充质干细胞来源的外泌体持续释放miR-21,可抑制卵巢早衰中卵巢颗粒细胞的凋亡

Zhang Xiaofei, Ma Linzi, Liu Xiaotong, Zhou Xingyu, Wang Ao, Lai Yunhui, Zhang Jun, Li Ying, Chen Shiling

Synergistic exacerbation of periprosthetic osteolysis by inflammatory bowel disease and titanium ions: Impaired osteogenesis of BMSCs via PI3K/AKT signaling.

炎症性肠病和钛离子协同加剧假体周围骨溶解:通过 PI3K/AKT 信号通路损害 BMSC 的成骨作用

Ming Panpan, Li Kang, Zhu Wenqing

Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K/AKT pathway.

基质硬度通过 ITGB1-PI3K/AKT 通路调节葡萄糖-6-磷酸脱氢酶的表达,从而介导肝细胞癌的索拉非尼耐药性

Ren Ruimei, Zhang Shan, Peng Zhan, Ji Xiaomeng, Song Hao, Wang Qiuxiao, Sun Xiangyin, Wang Huiyu, Dong Yinying
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 38